The Technology Co.,Ltd.

Equities

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
417 KRW 0.00% Intraday chart for The Technology Co.,Ltd. -9.74% -34.84%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd. CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd. CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd. CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd. CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion. CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd. CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion. CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd. CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd. CI
Hanju Chemical & Holdings Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Jiyuon Co., Ltd. CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 17.49999934 billion in funding from Jaanh Cosmetics, Inc. CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 12.49999978 billion in funding from CHOROKBAEM COMPANY Co., Ltd. CI
PharmswellBio Co., Ltd. announced that it has received KRW 4.999997086 billion in funding from Cube Partners, C.S. Global Co., Ltd. CI
PharmswellBio Co., Ltd.(KOSDAQ:A043090) dropped from S&P Global BMI Index CI
Chart The Technology Co.,Ltd.
More charts
The Technology Co Ltd, formerly Exergy21 Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company manly operates its business through four segments. The Distribution Business segment engages in the food processors, luxury goods, healthy food, kitchen appliances and home shopping goods distribution business. The PM business segment provides consulting services for real estate development, licensing, and contractor selection. The Pharmaceutical segment engages in ethanol and disinfectant manufacture business. The Other segment provides business support services. The Company also engages in information technology (IT) services, artificial intelligence (AI) and drone based security solutions, as well as heat pump system provision business.
More about the company
  1. Stock Market
  2. Equities
  3. A043090 Stock
  4. News The Technology Co.,Ltd.
  5. HanChang Biotech to Raise $9.2 Million Through Stock Offering